Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation

2016 ◽  
Vol 29 (6) ◽  
pp. 881-891 ◽  
Author(s):  
Paola Tomei ◽  
Valentina Masola ◽  
Simona Granata ◽  
Gloria Bellin ◽  
Pierluigi Carratù ◽  
...  
2016 ◽  
Vol 31 (suppl_1) ◽  
pp. i373-i373
Author(s):  
Paola Tomei ◽  
Valentina Masola ◽  
Pierluigi Carratù ◽  
Valentina Anna Ventura ◽  
Simona Granata ◽  
...  

2019 ◽  
Vol 63 (5) ◽  
pp. 579-594 ◽  
Author(s):  
Guillem Lambies ◽  
Antonio García de Herreros ◽  
Víctor M. Díaz

Abstract Cell migration is a multifactorial/multistep process that requires the concerted action of growth and transcriptional factors, motor proteins, extracellular matrix remodeling and proteases. In this review, we focus on the role of transcription factors modulating Epithelial-to-Mesenchymal Transition (EMT-TFs), a fundamental process supporting both physiological and pathological cell migration. These EMT-TFs (Snail1/2, Twist1/2 and Zeb1/2) are labile proteins which should be stabilized to initiate EMT and provide full migratory and invasive properties. We present here a family of enzymes, the deubiquitinases (DUBs) which have a crucial role in counteracting polyubiquitination and proteasomal degradation of EMT-TFs after their induction by TGFβ, inflammatory cytokines and hypoxia. We also describe the DUBs promoting the stabilization of Smads, TGFβ receptors and other key proteins involved in transduction pathways controlling EMT.


Sign in / Sign up

Export Citation Format

Share Document